sefulness of topical moisturizer in the treatment of skin xerosis in hemodilyzed patients
Not Applicable
- Conditions
- Skin xerosis in hemodialyzed patient
- Registration Number
- JPRN-UMIN000017016
- Lead Sponsor
- The Kidney Disease Clinic of Nippon Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients who received heparinoid- or urea -containing drugs within two weeks before signing the consent form. (2) Patients with/ with the past of extensive complications of the skin (burn, psoriasis etc.). (3) Patients with allergy to heparinoid. (4) Patients with hemorrhagic blood disease (hemophilia, thrombocytopenia, purpura etc.). (5) Patients who are expected a few bleeding causes a serious result. (6) Patients who participated in other clinical study within 4 months before starting study. (7) Patients who are unsuitable to the study at the investigator's discretion.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The water content of the stratum corneum
- Secondary Outcome Measures
Name Time Method Efficacy (Skin xerosis, pruritus, etc. ), Safety